Sue Desmond-Hellmann

Sue Desmond-Hellmann

Directeur/Membre du Conseil chez PFIZER INC.

Fortune : 96 992 $ au 31/08/2026

68 ans
Health Technology
Finance
Commercial Services

Profil

Susan D.
Desmond-Hellmann
is currently an Independent Director at Pfizer Inc. since 2020.
She is a Director at Bill & Melinda Gates Medical Research Institute, Gates Medical Research Institute, National Resilience, Inc., Stand Up To Cancer, and OpenAI Foundation.
She also serves as an Advisor at GV Management Co. LLC.
Formerly, Dr. Desmond-Hellmann was Chief Executive Officer at Gates Foundation Trust and Bill & Melinda Gates Foundation Trust (Investment Management) from 2014 to 2020.
She was a Director at Pfizer Inc. in 2020 and an Independent Director at Procter & Gamble Co. from 2011 to 2017.
She served as Director at Affymetrix, Inc. from 2004 to 2009 and Lead Independent Director at Meta Platforms, Inc. from 2015 to 2019.
Other former roles include Director at Biotechnology Innovation Organization, Associate Director-Clinical Cancer Research at Bristol-Myers Squibb Pharmaceutical Research Institute, President-Product Development at Genentech, Inc. from 2005 to 2009, Trustee at Howard Hughes Medical Institute, Inc., Chancellor at The University of California, San Francisco from 2009 to 2014, and Senior Advisor at BDT Capital LLC.
Education includes graduate studies at the University of California, Berkeley, and undergraduate and doctorate degrees from the University of Nevada.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
23/04/2026 3 408 ( 0% ) 96 992 $ 31/08/2026

Postes actifs de Sue Desmond-Hellmann

SociétésPosteDébut
PFIZER INC. Directeur/Membre du Conseil 01/01/2020
Directeur/Membre du Conseil -
Consultant / Advisor -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Gates Medical Research Institute
Directeur/Membre du Conseil -

Anciens postes connus de Sue Desmond-Hellmann

SociétésPosteFin
PFIZER INC. Directeur/Membre du Conseil 23/04/2020
Directeur Général 01/02/2020
Directeur Général 01/01/2020
░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Sue Desmond-Hellmann

Formation de Sue Desmond-Hellmann

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

94

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Finance

Technology Services

Commercial Services

Miscellaneous

Consumer Services

Consumer Services

Consumer Services

Bristol-Myers Squibb Pharmaceutical Research Institute

Finance

Finance

Commercial Services

Miscellaneous

Commercial Services

Gates Medical Research Institute

Health Technology

  1. Bourse
  2. Insiders
  3. Sue Desmond-Hellmann
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT